Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1956 2
1962 1
1963 1
1964 1
1966 1
1967 2
1968 3
1969 3
1970 10
1971 4
1972 1
1973 5
1974 3
1975 5
1976 2
1977 4
1978 5
1979 3
1980 2
1981 1
1982 4
1983 4
1984 5
1985 13
1986 12
1987 12
1988 19
1989 6
1990 18
1991 17
1992 25
1993 15
1994 22
1995 21
1996 39
1997 33
1998 25
1999 27
2000 38
2001 33
2002 20
2003 32
2004 34
2005 32
2006 43
2007 39
2008 30
2009 40
2010 46
2011 43
2012 46
2013 65
2014 61
2015 53
2016 50
2017 49
2018 56
2019 55
2020 53
2021 38
Text availability
Article attribute
Article type
Publication date

Search Results

1,233 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).
Boku N, Ryu MH, Kato K, Chung HC, Minashi K, Lee KW, Cho H, Kang WK, Komatsu Y, Tsuda M, Yamaguchi K, Hara H, Fumita S, Azuma M, Chen LT, Kang YK. Boku N, et al. Among authors: azuma m. Ann Oncol. 2019 Feb 1;30(2):250-258. doi: 10.1093/annonc/mdy540. Ann Oncol. 2019. PMID: 30566590 Free PMC article. Clinical Trial.
The CD28-B7 Family of Co-signaling Molecules.
Nagai S, Azuma M. Nagai S, et al. Among authors: azuma m. Adv Exp Med Biol. 2019;1189:25-51. doi: 10.1007/978-981-32-9717-3_2. Adv Exp Med Biol. 2019. PMID: 31758530 Review.
VISTA expressed in tumour cells regulates T cell function.
Mulati K, Hamanishi J, Matsumura N, Chamoto K, Mise N, Abiko K, Baba T, Yamaguchi K, Horikawa N, Murakami R, Taki M, Budiman K, Zeng X, Hosoe Y, Azuma M, Konishi I, Mandai M. Mulati K, et al. Among authors: azuma m. Br J Cancer. 2019 Jan;120(1):115-127. doi: 10.1038/s41416-018-0313-5. Epub 2018 Nov 9. Br J Cancer. 2019. PMID: 30382166 Free PMC article.
Dynamic Cardiolipin Synthesis Is Required for CD8+ T Cell Immunity.
Corrado M, Edwards-Hicks J, Villa M, Flachsmann LJ, Sanin DE, Jacobs M, Baixauli F, Stanczak M, Anderson E, Azuma M, Quintana A, Curtis JD, Clapes T, Grzes KM, Kabat AM, Kyle R, Patterson AE, Geltink RK, Amulic B, Steward CG, Strathdee D, Trompouki E, O'Sullivan D, Pearce EJ, Pearce EL. Corrado M, et al. Among authors: azuma m. Cell Metab. 2020 Dec 1;32(6):981-995.e7. doi: 10.1016/j.cmet.2020.11.003. Cell Metab. 2020. PMID: 33264603 Free PMC article.
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2).
Kato K, Satoh T, Muro K, Yoshikawa T, Tamura T, Hamamoto Y, Chin K, Minashi K, Tsuda M, Yamaguchi K, Machida N, Esaki T, Goto M, Komatsu Y, Nakajima TE, Sugimoto N, Yoshida K, Oki E, Nishina T, Tsuji A, Fujii H, Kunieda K, Saitoh S, Omuro Y, Azuma M, Iwamoto Y, Taku K, Fushida S, Chen LT, Kang YK, Boku N. Kato K, et al. Among authors: azuma m. Gastric Cancer. 2019 Mar;22(2):344-354. doi: 10.1007/s10120-018-0899-6. Epub 2018 Dec 1. Gastric Cancer. 2019. PMID: 30506519 Free PMC article. Clinical Trial.
A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer.
Bando H, Shimodaira H, Fujitani K, Takashima A, Yamaguchi K, Nakayama N, Takahashi T, Oki E, Azuma M, Nishina T, Hironaka S, Komatsu Y, Shitara K. Bando H, et al. Among authors: azuma m. Eur J Cancer. 2018 Mar;91:86-91. doi: 10.1016/j.ejca.2017.11.032. Epub 2018 Jan 30. Eur J Cancer. 2018. PMID: 29353164 Free article. Clinical Trial.
1,233 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page